Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carsten Hagemann

Showing results (61-70 of 62) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 62 results.
Journal for Immunotherapy of Cancer|June 3, 2026
Novel CAR T cell blend targeting PDPN and GD2 to overcome glioblastoma heterogeneityJulian Hübner, Marah Alsalkini, Rhonda McFleder, et al.
Journal of the National Cancer Institute|August 14, 2013
Effects of the selective MPS1 inhibitor MPS1-IN-3 on glioblastoma sensitivity to antimitotic drugsBakhos A Tannous, Mariam Kerami, Petra M Van der Stoop, et al.
Pageof 7

Showing results (61-70 of 62) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 62 results.
Journal for Immunotherapy of Cancer|June 3, 2026
Novel CAR T cell blend targeting PDPN and GD2 to overcome glioblastoma heterogeneityJulian Hübner, Marah Alsalkini, Rhonda McFleder, et al.
Journal of the National Cancer Institute|August 14, 2013
Effects of the selective MPS1 inhibitor MPS1-IN-3 on glioblastoma sensitivity to antimitotic drugsBakhos A Tannous, Mariam Kerami, Petra M Van der Stoop, et al.
Pageof 7